The Food and Drug Administration is removing the “black box” warnings from hormone replacement therapy products for menopause ...

The Food and Drug Administration announced that hormone therapies for menopause will no longer need a black box warning about ...

The Food and Drug Administration says it is removing safety warnings for many hormone therapy drugs prescribed to ease ...

The FDA announced on Monday it will remove the "black box" warning from hormone replacement therapy products for menopause.

The US Food and Drug Administration intends to remove most black box warnings from products containing estrogen and progestogen. The decision, announced Monday, is part of a campaign to promote wider ...

Marking a pivotal moment in women’s health, the U.S. Food and Drug Administration (FDA) on Monday initiated actions to remove “black box” warnings, the agency’s strongest safety alert, from hormone ...

In a pivotal move, the US Food and Drug Administration on Monday said it is taking steps to remove the lengthy “black box” ...

The removal of warning labels by FDA could benefit future generations of women who previously avoided hormone therapy due to ...

The decision aims to improve access to HRT by removing warnings about cardiovascular disease, breast cancer, and probable dementia. HHS has initiated removal of black box warnings on hormone ...